KRTX Description — Karuna Therapeutics Inc

Karuna Therapeutics is a clinical-stage biopharmaceutical company that focuses on transformative medicines for people living with psychiatric and neurological conditions. Co.'s proprietary product candidate, KarXT (xanomeline-trospium), an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS) and various peripheral tissues. KarXT combines xanomeline, a muscarinic agonist, with trospium, an approved muscarinic antagonist, to preferentially stimulate muscarinic receptors in the CNS. Co. is developing KarXT for the treatment of psychosis in adults with schizophrenia as well as for the treatment of psychosis in Alzheimer's disease.

Company Name: 
Karuna Therapeutics Inc
Number of ETFs Holding KRTX: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   KRTX Weight   KRTX Amount 
 VTI   0.02%   $182,790,299         
 VB   0.14%   $156,382,462         
 IWM   0.31%   $150,553,706         
 VBR   0.24%   $103,861,034         
 VXF   0.10%   $79,460,889         
 XBI   1.04%   $70,983,683         
 IWO   0.60%   $53,339,471         
 VHT   0.11%   $20,875,170         
 VTWO   0.29%   $16,028,388         
 ITOT   0.02%   $6,855,396         
List of all 28 ETFs holding KRTX »
Quotes delayed 20 minutes

Email EnvelopeFree KRTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (3.94 out of 4)
69th percentile
(ranked higher than approx. 69% of all stocks covered)
Based on data provided by Zacks Investment Research via

ETFs Holding KRTX | Karuna Therapeutics Inc | ETF Channel |

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.